Fate Therapeutics, Inc.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of …
Biotechnology
US, San Diego [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
Fate Therapeutics, Inc. has no acquisition track records yet.
M&A Deals · History
Fate Therapeutics, Inc. has no acquisition track records yet.